Literature DB >> 35968353

MIR133A regulates cell proliferation, migration, and apoptosis by targeting SOX9 in human colorectal cancer cells.

Santosh Lamichhane1, Ji-Su Mo2, Grinsun Sharma1, Sun-Myoung Joung1, Soo-Cheon Chae1,2.   

Abstract

The human microRNA 133A (MIR133A) was identified as a CRC-associated miRNA. It was down-regulated in human CRC tissues. We identified the putative MIR133A1 and A2 target genes by comparing the transcriptome analysis data of MIR133A1 and A2 knock-in cells with the candidate MIR133A target genes predicted by bioinformatics tools. We identified 29 and 33 putative MIR133A and A2 direct target genes, respectively. Among them, we focused on the master transcription regulator gene SRY-box transcription factor 9 (SOX9), which exhibits a pleiotropic role in cancer. We confirmed that SOX9 is a direct target gene of MIR133A by luciferase reporter assay, quantitative RT-PCR, and western blot analysis. Overexpression of MIR133A in CRC cell lines significantly decreased SOX9 and its downstream PIK3CA-AKT1-GSK3B-CTNNB1 and KRAS-BRAF-MAP2K1-MAPK1/3 pathways and increased apoptosis. Furthermore, functional studies reveal that cell proliferation, colony formation, and migration ability were significantly decreased by MIR133A-overexpressed CRC cell lines. Knockdown of SOX9 in CRC cell lines by SOX9 gene silencing showed similar results. We also used a xenograft model to show that MIR133A overexpression suppresses tumor growth and proliferation. Our results suggest that MIR133A regulates cell proliferation, migration, and apoptosis by targeting SOX9 in human colorectal cancer. AJCR
Copyright © 2022.

Entities:  

Keywords:  MIR133A; SOX9; apoptosis; cell proliferation; colorectal cancer

Year:  2022        PMID: 35968353      PMCID: PMC9360235     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  52 in total

1.  Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells.

Authors:  Sabine Stöckl; Richard J Bauer; Anja K Bosserhoff; Claudia Göttl; Joachim Grifka; Susanne Grässel
Journal:  J Cell Sci       Date:  2013-04-19       Impact factor: 5.285

2.  SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis.

Authors:  Yanxia Ma; Jonathan Shepherd; Dekuang Zhao; Lakshmi Reddy Bollu; William M Tahaney; Jamal Hill; Yun Zhang; Abhijit Mazumdar; Powel H Brown
Journal:  Mol Cancer Res       Date:  2020-07-13       Impact factor: 5.852

3.  SOXs in human prostate cancer: implication as progression and prognosis factors.

Authors:  Wei-de Zhong; Guo-qiang Qin; Qi-shan Dai; Zhao-dong Han; Shan-ming Chen; Xiao-hui Ling; Xin Fu; Chao Cai; Jia-hong Chen; Xi-bin Chen; Zhuo-yuan Lin; Ye-han Deng; Shu-lin Wu; Hui-chan He; Chin-lee Wu
Journal:  BMC Cancer       Date:  2012-06-15       Impact factor: 4.430

4.  SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling.

Authors:  Hongwei Liu; Zhixiong Liu; Bing Jiang; Renjun Peng; Zhiming Ma; Jingchen Lu
Journal:  Cell Biochem Biophys       Date:  2015-09       Impact factor: 2.194

5.  LncRNA SNHG14 Sponges miR-206 to Affect Proliferation, Apoptosis, and Metastasis of Hepatocellular Carcinoma Cells by Regulating SOX9.

Authors:  Rui-Xin Lin; Guo-Feng Zhan; Jia-Cheng Wu; He Fang; Shu-Li Yang
Journal:  Dig Dis Sci       Date:  2021-03-29       Impact factor: 3.487

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  The versatile functions of Sox9 in development, stem cells, and human diseases.

Authors:  Alice Jo; Sahitya Denduluri; Bosi Zhang; Zhongliang Wang; Liangjun Yin; Zhengjian Yan; Richard Kang; Lewis L Shi; James Mok; Michael J Lee; Rex C Haydon
Journal:  Genes Dis       Date:  2014-12

8.  microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.

Authors:  Lan-Xuan Huang; Chun-Yan Hu; Li Jing; Min-Cong Wang; Meng Xu; Jing Wang; Yu Wang; Ke-Jun Nan; Shu-Hong Wang
Journal:  Cancer Sci       Date:  2017-08-29       Impact factor: 6.716

Review 9.  Global colorectal cancer burden in 2020 and projections to 2040.

Authors:  Yue Xi; Pengfei Xu
Journal:  Transl Oncol       Date:  2021-07-06       Impact factor: 4.243

Review 10.  Development of MicroRNAs as Potential Therapeutics against Cancer.

Authors:  Noraini Abd-Aziz; Nur Izyani Kamaruzman; Chit Laa Poh
Journal:  J Oncol       Date:  2020-07-15       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.